Bureau Veritas acquires Advanced Testing Laboratory, a US leader in scientific sourcing
28 Juni 2022 - 07:30AM
GlobeNewswire Inc.
Bureau Veritas acquires Advanced Testing Laboratory, a US leader in
scientific sourcing
PRESS RELEASE
Neuilly-sur-Seine, France – June 28, 2022
Bureau Veritas
acquires Advanced Testing
Laboratory, a
US leader in scientific
sourcing
Expanding
BV’s footprint
in Consumer
Products and Consumer
Healthcare markets
Bureau Veritas, a world
leader in testing, inspection and certification, announced
the acquisition of Advanced Testing Laboratory (ATL), a leader in
scientific sourcing services for the North American Consumer
Healthcare Products, Cosmetics & Personal Care and Medical
Device markets.
Headquartered in Cincinnati, Ohio, ATL’s
services span the entire product life cycle, from research and
development to substance and product qualification to
manufacturing. Services include Analytical Chemistry, Engineering,
Life Science, Product Performance, Product Safety & Regulatory,
Quality Assurance and Regulatory Compliance.
The company employs over 500 people all over the
US. It generated revenue of approximately €31 million in 2021.
Didier Michaud-Daniel, Chief Executive
Officer of Bureau Veritas, commented:
“In line with our 2025 Strategy, we are
accelerating the diversification of the Consumer Products Services
division into new markets and service models. Through its strong
expertise in on-site scientific sourcing solutions and in lab-based
services, ATL will contribute to the expansion of BV’s footprint in
North America. This major step in our development enables us to
enter the fast-growing Consumer Healthcare market. I would like to
warmly welcome the ATL teams to Bureau Veritas.”
Greg Neal, Chief Executive Officer of
Advanced Testing
Laboratory, added:
“We are excited to join Bureau
Veritas and look forward to expanding the services we provide our
clients while sharing our unique scientific sourcing solution and
framework worldwide. Through our combined expertise, we will be
able to offer a unique scientific sourcing, supply chain management
and ESG solution to Consumer Healthcare Products and Medical Device
brands. Our clients will have access to a larger solutions support
base with the ability to replicate globally, amplifying the value
to our ATL client base.”
About Bureau Veritas Bureau
Veritas is a world leader in laboratory testing, inspection and
certification services. Created in 1828, the Group has more than
80,000 employees located in nearly 1,600 offices and laboratories
around the globe. Bureau Veritas helps its 400,000 clients improve
their performance by offering services and innovative solutions in
order to ensure that their assets, products, infrastructure and
processes meet standards and regulations in terms of quality,
health and safety, environmental protection and social
responsibility.Bureau Veritas is listed on Euronext Paris and
belongs to the CAC 40 ESG, CAC Next 20 and SBF 120
indices.Compartment A, ISIN code FR 0006174348, stock symbol:
BVI.For more information, visit www.bureauveritas.com, and follow
us on Twitter (@bureauveritas) and LinkedIn.
|
Our information is certified with blockchain technology.Check that
this press release is genuine at www.wiztrust.com. |
ANALYST/INVESTOR CONTACTS |
|
MEDIA CONTACTS |
Laurent Brunelle |
|
Caroline Ponsi Khider |
+33 (0)1 55 24 76 09 |
|
+33 (0)7 52 60 89 78 |
laurent.brunelle@bureauveritas.com |
|
caroline.ponsi-khider@bureauveritas.com |
|
|
|
Colin Verbrugghe |
|
Primatice |
+33 (0)1 55 24 77 80 |
|
thomasdeclimens@primatice.com |
colin.verbrugghe@bureauveritas.com |
|
armandrigaudy@primatice.com |
- Press Release_Bureau Veritas_ATL_062822_EN
Bureau Veritas (EU:BVI)
Historical Stock Chart
Von Feb 2023 bis Mär 2023
Bureau Veritas (EU:BVI)
Historical Stock Chart
Von Mär 2022 bis Mär 2023